Skip to main content

Novartis' Sandoz To Pay $195M For Price-Fixing

Pharmaceutical giant Novartis AG's subsidiary Sandoz Inc. has agreed to pay $195 million in penalties to avoid facing criminal charges in a price-fixing case.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.